Karman (KRMN) Q2 Revenue Jumps 35%

Karman (NYSE:KRMN) reported strong Q2 FY2025 results, with GAAP revenue surging 35.3% year-over-year to $115.1 million and non-GAAP EPS of $0.10, both surpassing Wall Street expectations. The aerospace and defense firm's funded backlog expanded significantly to $719.3 million, a 24.1% increase from Q4 FY2024, driven by double-digit growth across all three key end markets and strategic acquisitions. While adjusted EBITDA margin compressed to 30.7% due to acquisition-related costs and increased operating expenses post-IPO, management raised its full-year 2025 guidance, projecting robust revenue and adjusted EBITDA growth, underscoring confidence in continued demand for its mission-critical space and defense systems.

Analysis

Karman (NYSE:KRMN) delivered a robust financial performance for the second quarter of fiscal 2025, significantly exceeding analyst expectations on key metrics. The company reported a 35.3% year-over-year increase in GAAP revenue to $115.1 million, surpassing the consensus estimate of $107.6 million, driven by double-digit growth across its Hypersonics, Space, and Tactical Missiles segments. This top-line momentum is supported by a substantial funded backlog, which expanded by 24.1% since Q4 FY2024 to $719.3 million, indicating strong future revenue visibility. While non-GAAP EPS of $0.10 modestly beat forecasts, profitability faced headwinds. The adjusted EBITDA margin compressed by 150 basis points to 30.7%, a direct consequence of costs associated with recent acquisitions and a near-doubling of general and administrative expenses to $19.4 million, reflecting integration activities and post-IPO operational costs. Despite these margin pressures, management issued strong forward guidance, raising its full-year revenue and adjusted EBITDA outlook to levels implying approximately 32% year-over-year growth at the midpoint, signaling confidence in sustained demand and operational execution.

Key Decisions for Investors

• Given the strong top-line beat, significant backlog growth to $719.3 million, and upwardly revised full-year guidance, investors may view these results as a validation of Karman's growth strategy in high-demand defense sectors.
• It is critical to monitor the company's adjusted EBITDA margin and operating expense trends in coming quarters, as the current compression to 30.7% due to acquisition integration and higher public company costs represents a key risk to profitability.
• Investors should watch for the successful conversion of the expanded backlog into revenue and evidence of cost management, as the ability to stabilize margins while executing on growth will be a primary determinant of future stock performance.